EFFECT OF MAGNESIUM SULFATE AND PERSONALISED DIETARY GUIDANCE ON HEMODYNAMICS AND INFLAMMATORY CYTOKINES IN PREGNANCY-INDUCED HYPERTENSION

Hemodynamics and Inflammatory Cytokines in Pregnancy-Induced Hypertension

  • Miao Shen Department of Gynaecology and Obstetrics,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
  • Ying Zhuang Department of Gynaecology and Obstetrics,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
  • Yaning Zheng Department of Gynaecology and Obstetrics,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
  • Mengqin Wang Department of Gynaecology and Obstetrics,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
  • Jiexun Wang Department of Gynaecology and Obstetrics,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
  • Shuoying Lyu Department of Gynaecology and Obstetrics,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University,Nanjing,Jiangsu,210008,China.
DOI: https://doi.org/10.5937/jomb0-57165
Keywords: Magnesium sulfate, Pregnancy-induced hypertension, Personalized dietary guidance, Inflammatory cytokines, Hemodynamics, IL-6, IL-10, IL-1β.

Abstract


Introduction: Pregnancy-induced hypertension (PIH) is a significant cause of maternal and neonatal complications, often linked to vascular dysfunction and inflammatory responses. This study aimed to evaluate the effects of magnesium sulfate (MS) combined with personalized dietary guidance on hemodynamic parameters and inflammatory cytokine profiles in PIH patients.

Methods: A total of 108 PIH patients were randomly assigned to two groups: a research group (MS and dietary guidance) and a control group (dietary guidance only). Hemodynamic parameters, including systolic and diastolic blood pressure (SBP, DBP), plasma viscosity (PV), and erythrocyte aggregation index (EI), were measured, along with inflammatory cytokines (IL-6, IL-1β, IL-10), before and after treatment.

Results: The research group, which received both MS and dietary guidance, showed significant reductions in SBP, DBP, PV, and EI compared to the control group. Additionally, inflammatory cytokines IL-6 and IL-1β were significantly reduced in the research group, indicating an improvement in the inflammatory response. While IL-10 levels decreased in both groups, this change was not statistically significant.

Conclusion: The combination of magnesium sulfate and personalized dietary guidance effectively improves hemodynamic stability and reduces inflammatory markers in PIH patients. This intervention may offer beneficial effects for maternal and neonatal health by addressing both hypertension and inflammation associated with PIH.

References

1. Honigberg MC, Truong B, Khan RR, Xiao B, Bhatta L, Vy HMT, et al. Polygenic prediction of preeclampsia and gestational hypertension. Nat Med. 2023;29(6):1540-9.
2. Abubakar M, Rasool HF, Javed I, Raza S, Abang L, Hashim MMA, et al. Comparative Roles of IL-1, IL-6, IL-10, IL-17, IL-18, 1L-22, IL-33, and IL-37 in Various Cardiovascular Diseases With Potential Insights for Targeted Immunotherapy. Cureus. 2023;15(7):e42494.
3. Babić Leko M, Nikolac Perković M, Klepac N, Štrac D, Borovečki F, Pivac N, et al. IL-1β, IL-6, IL-10, and TNFα Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer's Disease Pathology. J Alzheimers Dis. 2020;75(3):1029-47.
4. Gyselaers W. Hemodynamic pathways of gestational hypertension and preeclampsia. Am J Obstet Gynecol. 2022;226(2S):S988-S1005.
5. Chappell LC, Tucker KL, Galal U, Yu LM, Campbell H, Rivero-Arias O, et al. Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals With Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical Trial. JAMA. 2022;327(17):1666-78.
6. Cagino K, Prabhu M, Sibai B. Is magnesium sulfate therapy warranted in all cases of late postpartum severe hypertension? A suggested approach to a clinical conundrum. Am J Obstet Gynecol. 2023;229(6):641-6.
7. Fishel Bartal M, Sibai BM. Eclampsia in the 21st century. Am J Obstet Gynecol. 2022;226(2S):S1237-S53.
8. Hauspurg A, Jeyabalan A. Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2022;226(2S):S1211-S21.
9. Sharma DD, Chandresh NR, Javed A, Girgis P, Zeeshan M, Fatima SS, et al. The Management of Preeclampsia: A Comprehensive Review of Current Practices and Future Directions. Cureus. 2024;16(1):e51512.
10. Cifkova R. Hypertension in Pregnancy: A Diagnostic and Therapeutic Overview. High Blood Press Cardiovasc Prev. 2023;30(4):289-303.
11. Meng J, Du J, Diao X, Zou Y. Effects of an evidence-based nursing intervention on prevention of anxiety and depression in the postpartum period. Stress Health. 2022;38(3):435-42.
12. Schuermans A, Truong B, Ardissino M, Bhukar R, Slob EAW, Nakao T, et al. Genetic Associations of Circulating Cardiovascular Proteins With Gestational Hypertension and Preeclampsia. JAMA Cardiol. 2024;9(3):209-20.
13. de Almeida LGN, Young D, Chow L, Nicholas J, Lee A, Poon MC, et al. Proteomics and Metabolomics Profiling of Platelets and Plasma Mediators of Thrombo-Inflammation in Gestational Hypertension and Preeclampsia. Cells. 2022;11(8).
14. Henderson I, Quenby S. Gestational hypertension and childhood atopy: a Millennium Cohort Study analysis. Eur J Pediatr. 2021;180(8):2419-27.
15. Imanpour V, Khoshhali M, Goodarzi-Khoigani M, Kelishadi R. Systematic review and meta-analysis of nutritional interventions to prevent of gestational hypertension or/and preeclampsia among healthy pregnant women. J Res Med Sci. 2023;28:25.
16. Brookfield KF, Mbata O. Magnesium Sulfate Use in Pregnancy for Preeclampsia Prophylaxis and Fetal Neuroprotection: Regimens in High-Income and Low/Middle-Income Countries. Obstet Gynecol Clin North Am. 2023;50(1):89-99.
17. Pascoal ACF, Katz L, Pinto MH, Santos CA, Braga LCO, Maia SB, et al. Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia: A randomized clinical trial. Medicine (Baltimore). 2019;98(32):e16779.
18. Xiang C, Zhou X, Zheng X. Magnesium Sulfate in combination with Nifedipine in the treatment of Pregnancy-Induced Hypertension. Pak J Med Sci. 2020;36(2):21-5.
19. Rodriguez-Iturbe B, Pons H, Johnson RJ. Role of the Immune System in Hypertension. Physiol Rev. 2017;97(3):1127-64.
20. Bajpai D, Popa C, Verma P, Dumanski S, Shah S. Evaluation and Management of Hypertensive Disorders of Pregnancy. Kidney360. 2023;4(10):1512-25.
21. Shepherd E, Gomersall JC, Tieu J, Han S, Crowther CA, Middleton P. Combined diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2017;11(11):CD010443.
22. Brown J, Alwan NA, West J, Brown S, McKinlay CJ, Farrar D, et al. Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017;5(5):CD011970.
23. Iravani K, Salari M, Doostkam A, Mehrabi F, Ghadimi M. Magnesium sulfate administration in difficult laryngoscopy: An effective and safe method. Am J Otolaryngol. 2022;43(4):103479.
24. He W, Wang QH, Li JW, Wang YY, Luo XM, Wan L, et al. Adrenocorticotropic hormone combined with magnesium sulfate therapy for infantile epileptic spasms syndrome: a real-world study. World J Pediatr. 2023.
Published
2025/04/08
Issue
Vol. 44 No. 6 (2025): Journal of Medical Biochemistry
Section
Original paper

Copyright (c) 2025 Shuoying Lye

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.